GlassScriptPhysician profile
Joshua Mark Eisenberg
NPI 1891289351
$12,462.83
in general payments reported to CMS, 2019-2025
10 companies · $1,848 in 2025
The $1,848 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $471 · 2021: $995 · 2022: $2,196 · 2023: $3,503 · 2024: $3,319 · 2025: $1,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,505 · Travel and Lodging: $4,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,504.92 |
| Travel and Lodging | $4,164.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,982.69 | 2021-2025 | Cd Horizon Spinal System, Clydesdale Ptc Spinal System, Mazor X System |
| Globus Medical, INC. | $3,223.74 | 2021-2025 | Direct Look, Excelsiusgps Robotic Navigation System, Alif |
| Nuvasive, INC. | $2,039.71 | 2022-2023 | Tlif, Xlif, Reline |
| Stryker Corporation | $929.93 | 2019-2024 | N/A, T2, Variax |
| Alphatec Spine, INC | $713.29 | 2024-2025 | Other - Miscellaneous |
| Zimmer Biomet Holdings, INC. | $551.56 | 2022-2025 | Rosa, Persona, Oss Orthopedic Salvage System |
| Wardlow Enterprises | $471.25 | 2020 | |
| Cerapedics INC. | $395.38 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $88.90 | 2021-2025 | Na |
| Medtronic USA, INC. | $66.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.